Avolynt is a clinical stage drug development company based in Research Triangle Park, North Carolina. The Company’s mission is to improve the lives of patients suffering from dysfunctions related to human metabolism. Avolynt’s team has significant discovery and development experience across the metabolic syndrome, including diabetes, obesity, and nonalcoholic steatohepatitis (NASH). The Company’s lead programs are in phase 2 and phase 3.


Progress Center – Cape Fear Building
3200 NC Hwy 54
Suite 100A
RTP, NC 27709

Additional Details

Arrived in RTP:

Get In Touch

(919) 659-5677
Mailing Address:
PO Box 13765
RTP, NC 27709
General Contact:
(919) 659-5677